Riskpilot← Back to searchSign inGet full accessBIGBIO Holstebro ApS
APSActiveCVR 20986697Enghaven 17Motion picture projection activities · NACE 5914Est. 199833 employeeswww.bigbio.dk
Revenue 2025
DKK 5,3M
+32% vs 2024
EBITDA margin
21.9%
+408% vs 2024
Equity ratio
8.4%
Financial strength
Net profit 2025
DKK -24K
+97% vs 2024
| Revenue | DKK 5,3M | +32% |
| EBITDA | DKK 1,2M | +408% |
| Net profit | DKK -24K | +97% |
| Total assets | DKK 12,2M | -1% |
| Equity | DKK 1M | -2% |
| Employees | 33 | — |
Legal name
BIGBIO Holstebro ApS
CVR number
20986697
Legal form
Anpartsselskab
NACE code
5914 · Motion picture projection activities
Founded
30. juni 1998
Share capital
DKK 501.000
Employees
33 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive biograf, handel, fabrikation og anden efter direktionens skøn dermed beslægtet virksomhed.
Address
Enghaven 17
Phone
+4597426060
Email
info.holstebro@bigbio.dk
Website
www.bigbio.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2.754 | 7.062 | 5.047 | 3.976 | 5.267 |
| Staff expenses | -2.812 | -3.581 | -3.860 | -3.749 | -4.115 |
| EBITDA | -58 | 3.481 | 1.187 | 227 | 1.153 |
| Depreciation & amort. | -1.299 | -1.241 | -1.182 | -1.176 | -1.115 |
| EBIT | -1.358 | 2.240 | 6 | -949 | 38 |
| Net financials | -154 | -122 | -167 | -141 | -65 |
| Profit before tax | -1.511 | 2.118 | -161 | -1.090 | -27 |
| Tax | -360 | 343 | -32 | -237 | -3 |
| Net profit | -1.151 | 1.774 | -129 | -853 | -24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16.919 | 18.613 | 13.501 | 12.254 | 12.174 |
| Equity | 1.260 | 3.034 | 1.905 | 1.052 | 1.028 |
| Long-term debt | 7.326 | 6.407 | 5.659 | 4.855 | 3.952 |
| Short-term debt | 8.086 | 8.960 | 5.797 | 6.317 | 7.194 |
| Total debt | 15.412 | 15.367 | 11.457 | 11.173 | 11.146 |
EBITDA margin
21.9%
This company
15.8%
Market median
+39% vs market
20212025
Equity ratio
8.4%
This company
38.2%
Market median
-78% vs market
20212025
Return on equity
-2.3%
This company
18.4%
Market median
-113% vs market
20212025
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212025
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20212025
Debt / equity
10.84×
This company
0.62×
Market median
-1648% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HO Management | Management | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 1998 – 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 25–33.32% | 2020 | |
| Company | 25–33.32% | 25–33.32% | 2020 | |
| Company | 20–24.99% | 20–24.99% | 2019 | |
| Company | 20–24.99% | 20–24.99% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HELO HOLDING ApS
BIGBIO Holstebro ApS Board members of BIGBIO Holstebro ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Obel Nielsen | Management | 0 companies |
| Anne Louise Obel | Chairman | 0 companies |
| Birthe Marie Obel | Board of Directors | 0 companies |